Počet záznamov: 1
Experience of using genetically engineered biological drugs in children with a systemic form of JIA in the Karaganda region
SYS 0191746 LBL 00000naa^^22^^^^^^^^450 005 20231221141821.3 100 $a 20231011d2023 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Experience of using genetically engineered biological drugs in children with a systemic form of JIA in the Karaganda region $f Tattigul Kenzhetaeva ... [et al.] 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0191463 $1 011 $a 0006-9248 $1 200 1 $a Bratislavské lekárske listy $d Bratislava medical journal $e international journal for biomedical sciences and clinical medicine $z eng $v Vol. 124, no. 8 (2023), s. 615-621 $1 210 $a Bratislava $c AEPress $d 2023 $1 215 $a s. 557-629 606 1-
$3 sllk_un_auth*d001171 $a artritída juvenilná $x farmakoterapia $2 mesh 606 1-
$3 sllk_un_auth*d004351 $a rezistencia lieková $2 mesh 606 2-
$3 sllk_un_auth*d001691 $a terapia biologická $2 mesh 606 2-
$3 sllk_un_auth*d053590 $a antagonista receptora pre interleukín 1 $2 mesh 606 2-
$3 sllk_un_auth*d019947 $a receptory pre interleukín-6 $x antagonisty a inhibítory $2 mesh 606 2-
$3 sllk_un_auth*d016896 $a výsledok liečby $2 mesh 606 2-
$3 sllk_un_auth*d002648 $a dieťa $9 C $2 mesh 607 $3 sllk_un_auth*d007623 $a Kazachstan $2 mesh 610 2-
$a tocilizumab 610 2-
$a anakinra 610 2-
$a účinnosť a bezpečnosť liečby 610 2-
$a vyhodnotenie súboru detských pacientov 701 -1
$3 sllk_un_auth*0059095 $a Kenzhetaeva $b Tattigul $4 070 801 -0
$a SK $b BA006 $c 20231011 $g AACR2
Počet záznamov: 1